Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis
Abstract There are limited therapeutic methods for triple negative breast cancer in the clinic, which is easy to progress into the brain to form metastatic lesions and evolve into the terminal stage. Because both the primary cancer and the brain metastasis have high glycolysis, we hypothesize that l...
Guardado en:
Autores principales: | Tieying Dong, Zhaoliang Liu, Qijia Xuan, Zhuozhong Wang, Wenjie Ma, Qingyuan Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/18d8357cacd34779a33c7e8abce0070c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications
por: Mona Ebadi, et al.
Publicado: (2020) -
Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
por: Wen-Hung Kuo, et al.
Publicado: (2012) -
Study of the effect of the LDH cations precursors in the removal of arsenic in aqueous solution
por: María Martha Barroso Quiroga, et al.
Publicado: (2021) -
Application of LDH assay for therapeutic efficacy evaluation of ex vivo tumor models
por: Megan C. Cox, et al.
Publicado: (2021) -
High-efficiency CO2 separation using hybrid LDH-polymer membranes
por: Xiaozhi Xu, et al.
Publicado: (2021)